A Pipeline to Call Multilevel Expression Changes between Cancer and Normal Tissues and Its Applications in

Wei Gao1, Jianwei Yang1, Changhua Zhuo2

  • 1Departments of Internal Medicine-Oncology, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, Fujian 350014, China.

Insights

This study introduces a new pipeline to analyze gastric cancer by examining gene expression changes and networks. It identifies key genes and pathways, aiding in understanding cancer development and finding new drug treatments.

Area of Science:

  • Genomics
  • Cancer Biology
  • Bioinformatics

Background:

  • Gastric cancer research often focuses on single gene expression changes.
  • Gene coexpression and network alterations are also crucial in gastric cancer development.

Purpose of the Study:

  • To develop a comprehensive pipeline for analyzing gastric cancer at multiple molecular levels.
  • To identify potential drug repurposing candidates for gastric cancer treatment.

Main Methods:

  • Utilized a dataset of 242 gastric cancer samples from The Cancer Genome Atlas (TCGA).
  • Performed differential gene expression, gene coexpression network analysis, and differential pathway analysis.
  • Screened 2703 drugs for potential therapeutic applications based on identified gene perturbations.

Main Results:

  • Identified significant differences in gene expression and pathways between gastric tumors and adjacent normal tissues.
  • Highlighted the interleukin-4 and interleukin-13 signaling pathway as notably altered.
  • Found a substantial overlap between perturbed genes and drug targets.

Conclusions:

  • The developed pipeline offers a multi-level approach to understanding gastric cancer.
  • This method can aid in discovering novel therapeutic strategies and drug repurposing for gastric cancer.

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...